通过聚合诱导的自我组装制备的pH-响应的聚合物囊泡,用于控制的5-甲输送
Laila M Alhaidari1, Reema Altariqi1, Thana Alkhamis1
1Department of Chemistry, Faculty of Science, University of Majmaah Majmaah 11952 Saudi Arabia l.alhaidari@mu.edu.sa.
RSC advances
|December 15, 2025
概括
这项研究引入了适应pH值的聚二二二胺乙烯甲基酸盐 (PDPA) 囊泡,用于控制的5-甲 (5-FU) 输送. 这些新型纳米载体在酸性条件下证明了有效的癌细胞向和药物释放.
科学领域:
- 聚合物化学 聚合物化学
- 纳米技术 纳米技术
- 药物输送系统是药物输送系统.
背景情况:
- 响应刺激的聚合物囊泡显示出控制化疗输送的潜力.
- 众所周知,聚二二二胺乙基甲酸盐 (PDPA) 囊泡会释放适应pH的药物,但它们与5-fluorouracil (5-FU) 的使用尚未探索.
研究的目的:
- 调查基于PDPA的囊泡对于pH触发的5-FU输送的有效性.
- 评估这些新型纳米载体的抗癌活性和细胞吸收.
主要方法:
- 通过使用RAFT聚合,通过聚合诱导的自我组装 (PISA) 进行囊泡制备.
- 在不同pH值下评估囊泡稳定性和药物释放.
- 使用HCT116细胞和共聚焦激光扫描显微镜 (CLSM) 进行细胞吸收研究的细胞毒性测定.
主要成果:
- 在酸性条件下成功合成了PDPA囊泡并证明了pH触发的分解和加速的5-FU释放.
- 囊泡载入的5-FU在HCT116细胞中表现出与自由的5-FU相似的抗癌疗效.
- 空白囊泡没有显示有毒性,CLSM证实了纳米载体的有效细胞吸收.
结论:
- 基于PDPA的囊泡代表了一种新且有效的纳米平台,用于pH响应的5-FU输送.
- 开发的系统为向化疗提供了一种有前途的方法,其疗效提高,毒性降低.
相关概念视频
Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


